• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Silo Pharma Inc (OP: SILO )

    N/A UNCHANGED
    Last Price Updated: 3:23 PM EDT, Sep 14, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Silo Pharma Inc

    < Previous 1 2 3 4 Next >
    Illinois Advocates Prepare to Introduce First Psychedelics Measure
    Via Investor Brand Network
    PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Announces Milestone in Psilocybin Study on Parkinson’s Patients
    Via Investor Brand Network
    FDA Expands Access to MDMA for Treatment of PTSD
    Via Investor Brand Network
    Exposures Product Safety
    PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) CEO Featured in Bell2Bell Podcast Episode
    Via Investor Brand Network
    First Psychedelic Trial Clinic Set to Launch in London
    Via Investor Brand Network
    Silo Pharma Inc. (SILO) Spotlight: Ketamine
    Via Investor Brand Network
    Silo Pharma Inc. (SILO) Spotlight: Ketamine
    Via Investor Brand Network
    Researchers Have Found Brain Cells That Die Due to Parkinson’s Disease
    Via Investor Brand Network
    Study Finds Service Dogs Help Individuals with PTSD
    Via Investor Brand Network
    3 Psychedelic Documentaries You Can Watch on YouTube
    Via Investor Brand Network
    PsychedelicNewsBreaks – Silo Pharma Inc. (SILO), Frontage Laboratories to Collaborate in Pharmacokinetic Study
    Via Investor Brand Network
    New Study Sheds Light on Inflammation Linked to COVID-19
    Via Investor Brand Network
    Exposures COVID-19
    Studies Find Link Between ADHD, Fibromyalgia
    Via Investor Brand Network
    Research Highlights the High Economic Cost of PTSD
    Via Investor Brand Network
    Advocates Urge Use of Alternative Treatments to Curb Veteran Suicides
    Via Investor Brand Network
    PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Focusing on Largely Underserved Indications
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Study Evalutes Possible Link Between Parkinson’s Disease, Autoimmune Malfunction
    Via Investor Brand Network
    Study Finds That Psychedelics Free Up Brains of Individuals with Depression
    Via Investor Brand Network
    Silo Pharma Inc. (SILO) Advances with Pharmacokinetic Study – but What is Pharmacokinetics?
    Via Investor Brand Network
    Scientists Stop Memory Decay by Administering Nasal Therapy to Mice
    Via Investor Brand Network
    BioMedNewsBreaks – Silo Pharma Inc. (SILO) Produces First Batch of SPU-21 Liposomes for RA Study
    Via Investor Brand Network
    Silo Pharma Inc. (SILO) Emerging Leader as Psychedelics ‘on the Cusp of Entering Mainstream Psychiatry’
    Via Investor Brand Network
    BioMedNewsBreaks – Why Silo Pharma Inc. (SILO) Is ‘One to Watch’
    Via Investor Brand Network
    BioMedNewsBreaks – Silo Pharma Inc. (SILO) Enters Agreement to Significantly Advance Technologies ‘Closer to the Clinic’
    Via Investor Brand Network
    BioMedNewsBreaks – Silo Pharma Inc. (SILO) Initiates Coverage with InvestorBrandNetwork
    Via Investor Brand Network
    Silo Pharma Inc. (SILO) Is ‘One to Watch’
    Via Investor Brand Network
    4 Penny Stocks Insiders Are Buying
    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... 
    Via Benzinga
    Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer's Disease
    Agreement Provides for Option to License Alzheimer’s Therapeutic Englewood Cliffs, NJ, October 27, 2021 -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage... 
    Via Benzinga
    Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
    The Week In Psychedelics 
    Via Benzinga
    There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
    Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.